Show simple item record

dc.contributor.authorRos Cervera, Gonzalo
dc.contributor.otherSánchez Pellicer, Pedro
dc.date.accessioned2023-07-03T11:21:23Z
dc.date.available2023-07-03T11:21:23Z
dc.date.issued2022-10
dc.identifier.urihttp://hdl.handle.net/10952/6540
dc.descriptionRandomized, double-blind, placebo-controlled clinical trial, to evaluate a probiotic preparation efficacy administered for 12 weeks on the evolution of atopic dermatitis patients between 3 and 17 years old A total of 60 patients diagnosed with atopic dermatitis will participate in the study, who will be randomized into two treatment groups in a 1:1 ratio (30 patients per group). The intervention groups are differentiated according to the treatment to be received: probiotic or placebo of similar appearance, along with standard therapy according to clinical guidelines. The 12 weeks of treatment are structured into 4 face-to-face visits: Visit 1 (initial; week 0), Visit 2 (week 4), Visit 3 (week 8) and Visit 4 (final; week 12).es
dc.description.abstractRandomized, double-blind, placebo-controlled clinical trial, to evaluate an oral probiotic effectiveness administered as adjuvant treatment for 12 weeks on the atopic dermatitis evolution in patients between 3 and 17 years oldes
dc.language.isoenes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAtopic dermatitises
dc.subjectAtopic eczemaes
dc.subjectProbioticses
dc.subjectMicrobiotaes
dc.subjectMicrobiomees
dc.titleRandomized, double-blind, placebo-controlled clinical trial to evaluate a probiotic preparation efficacy as adjuvant treatment in patients between 3 and 17 years old with atopic dermatitises
dc.typeotheres
dc.rights.accessRightsopenAccesses
dc.description.disciplineCiencias de la Alimentaciónes
dc.description.disciplineMedicinaes


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional